To the attention of Contract Research Organisations conducting clinical trials in Romania
The current epidemiological context requires measures for public protection, patients / subjects enrolled in clinical trials included.
Therefore, the NAMMDR requests companies conducting clinical trials in Romania to undertake the following:
– establish the potential impact of general protection measures against the COVID-19 pandemic on ongoing activities within each clinical trial;
– notify the NAMMDR on their specific measures plan; on a case-by-case basis, these may be considered emergency safety measures with direct implementation.